AzTrials
AzTrials

ObesityNCT07740902

CHANGES IN SLEEP QUALITY AND BODY COMPOSITION FOLLOWING A MULTIMODAL LIFESTYLE INTERVENTION IN OLDER WOMEN

A study testing Multimodal Lifestyle Intervention in people with Obesity and Overweight (BMI > 25), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This single-arm pilot study evaluated changes in sleep quality, body composition, biochemical parameters, physical activity, and psychological well-being following a 12-week multimodal lifestyle intervention in overweight and obese women aged 60 years and older. Read more about this study

Who is it for?
Ages 60 years and older, women only
Conditions the study is for
Obesity, Overweight (BMI > 25), Sleep Quality
What is being tested?
Multimodal Lifestyle Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jan 2024to 15 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women aged 60 years or older
  • Being overweight or obese
  • Having access to nutrition counseling and psychological support services at the Healthy Living Center
  • Willingness to participate in the 12-week lifestyle intervention
  • Provision of informed consent

Who cannot join

  • Age under 60 years
  • Inability to adhere to the nutrition program
  • Inability to adhere to the walking program
  • Following a specific diet at the time of enrollment
  • Presence of serious chronic kidney, heart, or endocrine disease
  • Presence of severe depressive problems

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Healthy Living Center, Karabük

    Karabük

Other trials in Turkey (Türkiye)

About this study

This single-arm pilot study evaluated changes in sleep quality, body composition, biochemical parameters, physical activity, and psychological well-being following a 12-week multimodal lifestyle intervention in overweight and obese women aged 60 years and older. The intervention included individualized nutrition counseling, regular psychological support, and encouragement to walk for at least 150 minutes per week. Participants were assessed at baseline and at the end of week 12. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index. Secondary outcomes included anthropometric measurements, biochemical parameters, physical activity level, and psychological well-being.

Read the detailed description

This study was designed as a single-arm, pre-post pilot study to evaluate the preliminary effects of a 12-week multimodal lifestyle intervention on sleep quality, body composition, biochemical parameters, physical activity, and psychological well-being in overweight and obese women aged 60 years and older.

The study was conducted at a Healthy Living Center in Karabük, Türkiye. Volunteer women aged 60 years and older who were overweight or obese and had access to healthy diet consultation and psychological support services were enrolled. The intervention consisted of individualized nutrition counseling delivered by a registered dietitian, regular psychological support provided every two weeks, and encouragement to perform walking activity for at least 150 minutes per week. Nutrition counseling was tailored according to individual body composition results, lifestyle, dietary habits, and estimated daily energy requirements. Participants attended weekly face-to-face consultations with the dietitian during the 12-week intervention period.

Participants were assessed at baseline and at week 12. The primary outcome was change in sleep quality, assessed using the Pittsburgh Sleep Quality Index. Secondary outcomes included changes in anthropometric measurements, including body weight, body mass index, muscle mass, and body water ratio; biochemical parameters, including fasting blood glucose, fasting insulin, lipid profile, thyroid-stimulating hormone, aspartate aminotransferase, and alanine aminotransferase; physical activity level assessed using the International Physical Activity Questionnaire-Short Form; and psychological well-being assessed using the Psychological Well-Being Scale in the Elderly.

The study aimed to provide preliminary evidence on whether a combined lifestyle approach involving nutrition counseling, psychological support, and regular walking may be associated with improvements in sleep quality and selected health-related outcomes in older women with overweight or obesity. Because this was a single-arm pilot study without a control group, the findings are intended to inform future controlled studies rather than to establish causal effectiveness.

Being tested
Multimodal Lifestyle Intervention
Keywords
Older women, Lifestyle intervention, Nutrition counseling, Sleep quality, Body composition
Medical subject headings
Obesity, Overweight, Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multimodal Lifestyle InterventionBehavioural

    The intervention consisted of individualized nutrition counseling provided by a registered dietitian, psychological support provided every two weeks, and recommendations for regular walking activity for at least 150 minutes per week over a 12-week period.

Study groups in NCT07740902
Study groupRoleWhat they receive
Multimodal Lifestyle Intervention GroupExperimentalParticipants received a 12-week multimodal lifestyle intervention including individualized nutrition counseling, psychological support every two weeks, and recommendations for regular walking activity for at least 150 minutes per week.
Receives: Behavioral: Multimodal Lifestyle Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pittsburgh Sleep Quality Index total score

    Sleep quality was assessed using the Pittsburgh Sleep Quality Index. The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality.

    Measured: Baseline and week 12

Secondary outcomes (15)
  1. Change in body weight measured in kilograms

    Body weight was measured in kilograms at baseline and week 12. The change in body weight over the 12-week intervention period was evaluated.

    Measured: Baseline and week 12

  2. Change in body mass index (BMI) (kg/m²)

    Body mass index was calculated as weight in kilograms divided by height in meters squared. The change in BMI from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  3. Change in muscle mass measured by bioelectrical impedance analysis (kg)

    Muscle mass was assessed using bioelectrical impedance analysis and reported in kilograms. The change in muscle mass from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  4. Change in body water percentage measured by bioelectrical impedance analysis

    Body water percentage was assessed using bioelectrical impedance analysis. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  5. Change in fasting blood glucose concentration (mg/dL)

    Fasting blood glucose was measured in mg/dL. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  6. Change in fasting serum insulin concentration (mIU/mL)

    Fasting insulin was measured in mIU/mL. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  7. Change in total cholesterol concentration(mg/dL)

    Total cholesterol was measured in mg/dL. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  8. Change in LDL cholesterol concentration (mg/dL)

    LDL cholesterol was measured in mg/dL. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  9. Change in HDL cholesterol concentration (mg/dL)

    HDL cholesterol was measured in mg/dL. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  10. Change in serum triglyceride concentration (mg/dL)

    Triglycerides were measured in mg/dL. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  11. Change in thyroid-stimulating hormone concentration (mIU/L)

    Thyroid-stimulating hormone was measured in mIU/L. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  12. Change in aspartate aminotransferase activity (IU/L)

    Aspartate aminotransferase was measured in IU/L. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  13. Change in alanine aminotransferase activity (U/L)

    Alanine aminotransferase was measured in U/L. The change from baseline to week 12 was evaluated.

    Measured: Baseline and week 12

  14. Change in Psychological Well-Being Scale in the Elderly total score

    Psychological well-being was assessed using the Psychological Well-Being Scale in the Elderly. Higher scores indicate greater psychological well-being.

    Measured: Baseline and week 12

  15. Change in International Physical Activity Questionnaire-Short Form total score

    Physical activity was assessed using the International Physical Activity Questionnaire-Short Form and reported as MET-minutes/week.

    Measured: Baseline and week 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2026
  2. Study start15 Jan 2024
  3. Primary completion30 Jun 2024
  4. Study completion15 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Single-arm, pre-post pilot study. All participants received a 12-week multimodal lifestyle intervention including individualized nutrition counseling, psychological support, and regular walking recommendations. Outcomes were assessed at baseline and at week 12.
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07740902
Sponsor's protocol ID
KBU-NICREC-2023-1607
Status last verified
Jun 2026
First submitted
23 Jun 2026
Last updated
3 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be publicly shared due to participant privacy and ethical restrictions.

Questions about this trial

What is this clinical trial studying?

A study testing Multimodal Lifestyle Intervention in people with Obesity and Overweight (BMI > 25), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pittsburgh Sleep Quality Index total score (time frame: Baseline and week 12). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in